171 related articles for article (PubMed ID: 37099030)
41. Lymphoplasmacytic lymphoma with IgA paraproteinemia mimicking Waldenstrom's Macroglobulinemia.
Basu D; Pathak D; Shyambabu C; Koner BC; Swaminathan RP
Indian J Pathol Microbiol; 2004 Oct; 47(4):515-7. PubMed ID: 16295380
[TBL] [Abstract][Full Text] [Related]
42. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.
Treon SP; Xu L; Yang G; Zhou Y; Liu X; Cao Y; Sheehy P; Manning RJ; Patterson CJ; Tripsas C; Arcaini L; Pinkus GS; Rodig SJ; Sohani AR; Harris NL; Laramie JM; Skifter DA; Lincoln SE; Hunter ZR
N Engl J Med; 2012 Aug; 367(9):826-33. PubMed ID: 22931316
[TBL] [Abstract][Full Text] [Related]
43. Waldenstrom's macroglobulinemia presenting as Goodpasture's syndrome.
Gandhi S; Little MA; Farrington K
Ren Fail; 2004 Sep; 26(5):591-6. PubMed ID: 15526921
[TBL] [Abstract][Full Text] [Related]
44. Novel agents in the treatment of Waldenström's macroglobulinemia.
Treon SP; Hatjiharissi E; Leleu X; Moreau AS; Roccaro A; Hunter ZR; Soumerai JD; Ciccarelli B; Xu L; Sacco A; Ngo HT; Jia X; Yang C; Adamia S; Branagan AR; Ho AW; Santos DD; Tournilhac O; Manning RJ; Leduc R; O'Connor K; Nelson M; Patterson CJ; Ghobrial I
Clin Lymphoma Myeloma; 2007 Aug; 7 Suppl 5():S199-206. PubMed ID: 17877845
[TBL] [Abstract][Full Text] [Related]
45. Waldenström's macroglobulinemia.
Dimopoulos MA; Anagnostopoulos A
Best Pract Res Clin Haematol; 2005; 18(4):747-65. PubMed ID: 16026748
[TBL] [Abstract][Full Text] [Related]
46. Neuropathic joint disease (Charcot joints) in Waldenström's macroglobulinemia with amyloidosis.
Scott RB; Elmore SM; Brackett NC; Harris WO; Still WJ
Am J Med; 1973 Apr; 54(4):535-8. PubMed ID: 4633108
[No Abstract] [Full Text] [Related]
47. Peripheral neuropathy as clinical onset of monoclonal IgM/k-related amyloidosis.
Briani C; Ferrari S; Berno T; Visentin A; Cacciavillani M; Cavallaro T; Fedrigo M; Rizzo S; Salvalaggio A; Trentin L; Piazza F
J Peripher Nerv Syst; 2023 Jun; 28(2):262-265. PubMed ID: 36859783
[TBL] [Abstract][Full Text] [Related]
48. Waldenstrom's macroglobulinemia: Recent advances in biology and therapy.
Neparidze N; Dhodapkar MV
Clin Adv Hematol Oncol; 2009 Oct; 7(10):677-81, 687-90. PubMed ID: 20040909
[TBL] [Abstract][Full Text] [Related]
49. Amyloid arthritis associated with Waldenstrom's macroglobulinemia.
Goldberg LS; Fisher R; Castronova EA; Calabro JJ
N Engl J Med; 1969 Jul; 281(5):256-7. PubMed ID: 4978194
[No Abstract] [Full Text] [Related]
50. Myelopathy from Waldenström's macroglobulinemia: improvement after Rituximab therapy.
Liberato B; Riethmuller A; Comenzo RL; Lis E; Raizer JJ
J Neurooncol; 2003 Jun; 63(2):207-11. PubMed ID: 12825826
[TBL] [Abstract][Full Text] [Related]
51. [Diffuse pulmonary amylosis. Apropos of 2 cases associated with Waldenstrom's disease].
Martin M; Peltier P; Le Lann P; Garand R; Gaillard F
Poumon Coeur; 1982; 38(6):355-8. PubMed ID: 6819555
[TBL] [Abstract][Full Text] [Related]
52. IgM monoclonal gammopathy of undetermined significance (MGUS) and smoldering Waldenström's macroglobulinemia (SWM).
Kyle RA; Dispenzieri A; Kumar S; Larson D; Therneau T; Rajkumar SV
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):74-6. PubMed ID: 21454195
[TBL] [Abstract][Full Text] [Related]
53. How to manage Waldenstrom's macroglobulinemia.
Buske C; Leblond V
Leukemia; 2013 Apr; 27(4):762-72. PubMed ID: 23385376
[TBL] [Abstract][Full Text] [Related]
54. Idelalisib in a patient with refractory Waldenström's macroglobulinemia complicated by anuric renal failure: a case report.
D'Aveni-Piney M; Divoux M; Busby-Venner H; Muller M; Broséus J; Feugier P
J Med Case Rep; 2018 Jun; 12(1):164. PubMed ID: 29890999
[TBL] [Abstract][Full Text] [Related]
55. [Peritoneal amyloidosis in Waldenström's macroglobulinemia. X-ray computed tomographic aspects].
Raffi F; Lerat F; Cuillière P; Roudier JM; Le Bodic L; Rymer R
J Radiol; 1985 Nov; 66(11):735-8. PubMed ID: 3936921
[TBL] [Abstract][Full Text] [Related]
56. Minimal residual disease status improved the response evaluation in patients with Waldenström's macroglobulinemia.
Xiong W; Wang Z; Wang T; Yu Y; Huang Y; Sun H; Chen J; Lyu R; Wang H; Yan Y; Wang Q; Liu W; An G; Sui W; Huang W; Zou D; Xiao Z; Wang J; Ouyang G; Qiu L; Yi S
Front Immunol; 2023; 14():1171539. PubMed ID: 37234167
[TBL] [Abstract][Full Text] [Related]
57. Ptosis in Waldenström's macroglobulinemia.
Klapper SR; Jordan DR; Pelletier C; Brownstein S; Punja K
Am J Ophthalmol; 1998 Aug; 126(2):315-7. PubMed ID: 9727532
[TBL] [Abstract][Full Text] [Related]
58. [Waldenström's macroglobulinemia. Current developments in diagnostics and therapy].
Grunenberg A; Buske C
Internist (Berl); 2016 Mar; 57(3):238-44. PubMed ID: 26830425
[TBL] [Abstract][Full Text] [Related]
59. [Check-valve-mechanism in Waldenstrom's macroglobulinemia with pericollagen amyloidosis].
Missmahl HP; Gelinsky P; Braun HJ; Dold U
Med Welt; 1969 Jan; 1():39-41. PubMed ID: 4975603
[No Abstract] [Full Text] [Related]
60. Treatment and outcome patterns in European patients with Waldenström's macroglobulinaemia: a large, observational, retrospective chart review.
Buske C; Sadullah S; Kastritis E; Tedeschi A; García-Sanz R; Bolkun L; Leleu X; Willenbacher W; Hájek R; Minnema MC; Cheng M; Bilotti E; Graef T; Dimopoulos MA;
Lancet Haematol; 2018 Jul; 5(7):e299-e309. PubMed ID: 29958569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]